Patent details

EN | LT

LT - NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT

EN - NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07H 19/10
		C07H 19/20
		C07H 19/06
		C07H 19/12
		C07H 19/23
		A61K 31/7076
		A61P 9/00

European patent
(11)	Number of the document	3512860
(13)	Kind of document	T
(96)	European patent application number	17849975.2
	Date of filing the European patent application	2017-09-18
(97)	Date of publication of the European application	2019-07-24
(45)	Date of publication and mention of the grant of the patent	2020-11-25
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/CA2017/051095
	Date	2017-09-18

PCT application publication
(87)	Number	WO 2018/049534
	Date	2018-03-22

Priority applications
(30)	Number	Date	Country code
	201662395401 P	2016-09-16	US
	201662395411 P	2016-09-16	US
	201662395430 P	2016-09-16	US

Inventors
(72)	GUINDON, Yvan, CA MOCHIRIAN, Philippe, CA NEMER, Mona, CA

Grantee
(73)	LCB Pharma Inc., 12230 Avenue Lemesurier, Montréal, Québec H4K 2B3, CA Université D`Ottawa, 800 King Edward, 3042 VRTT, Ottawa, Ontario K1N 6N5, CA

Title
(54)	NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT
	NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2` POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT